These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7323040)

  • 41. N-aminoalkylsuccinimides as local anaesthetics. III. 1,2,3,4-Tetrahydronaphthalene-2-, indane-1-, and indane-2-spiro-3'-pyrrolidine-2'-5'-diones.
    Sandberg R; Domeij KE; Stening G; Willman N; Akerman B
    Acta Pharm Suec; 1980; 17(4):177-82. PubMed ID: 7468237
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical evaluation of an antithrombotic agent, Amisindione].
    Malanowicz W; Latallo Z; Zambrowicz K
    Pol Tyg Lek; 1970 Jul; 25(29):1095-8. PubMed ID: 5449816
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical study of a new anticoagulant: L.D. 4610].
    Audier M
    Mars Med; 1972; 109(5):385-7. PubMed ID: 4561955
    [No Abstract]   [Full Text] [Related]  

  • 44. [Inhibition of plasmatic coagulation: what is new?].
    Schwarz M; Bode C
    Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
    Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
    Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Histoautoradiographic and morphometric analysis of myocardial tissue in optimal regimen of hyperbaric oxygenation].
    Makhova AN; Lesnykh MP
    Fiziol Zh (1978); 1993; 39(2-3):18-22. PubMed ID: 8405540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of anticoagulant activity of ethanol extracts from leech in vitro].
    Feng GJ; Zhu ZG; Yu CL; Zhang Q; Chen NN; Lei LS; Wu SG
    Zhong Yao Cai; 2007 Aug; 30(8):909-11. PubMed ID: 18074833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Oxidative phosphorylation in cardiac muscle mitochondria during combined treatment of experimental myocardial infarct with potassium orotate and hyperbaric oxygenation].
    Reznikov KM; Petrov AV
    Vopr Med Khim; 1981; 27(1):31-5. PubMed ID: 7467205
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 52. [Synthesis and anticoagulant effect of some chromone-2-carboxylic acid amides].
    Tronche P; Couquelet J; Jolland P
    Ann Pharm Fr; 1965; 23(9):573-7. PubMed ID: 5851857
    [No Abstract]   [Full Text] [Related]  

  • 53. Bleeding time and oral anticoagulant therapy.
    Marongiu F; Biondi G; Sorano GG; Mameli G; Conti M; Mamusa AM; Balestrieri A
    Thromb Haemost; 1993 May; 69(5):523-4. PubMed ID: 8357429
    [No Abstract]   [Full Text] [Related]  

  • 54. Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants.
    Samama MM; Le Flem L; Guinet C; Gerotziafas G; Depasse F
    J Thromb Haemost; 2007 Dec; 5(12):2554-6. PubMed ID: 18034769
    [No Abstract]   [Full Text] [Related]  

  • 55. Novel anticoagulants based on inhibition of the factor VIIa/tissue factor pathway.
    Johnson K; Hung D
    Coron Artery Dis; 1998; 9(2-3):83-7. PubMed ID: 9647408
    [No Abstract]   [Full Text] [Related]  

  • 56. [Alternating effect of methyl derivatives of 2-phenylindandione-1, 3 on the content of free amino acids in rat kidney].
    Zalukaev LP; Voronkov MG; Kuzhman MI; Kozyreva OV
    Dokl Akad Nauk SSSR; 1976; 228(2):484-6. PubMed ID: 949927
    [No Abstract]   [Full Text] [Related]  

  • 57. [Characteristics of tissue respiration under the action of strophanthin, hyperbaric oxygenation and their combination in experimental myocardial necroses].
    Reznikov KM
    Vopr Med Khim; 1971; 17(5):499-503. PubMed ID: 5123467
    [No Abstract]   [Full Text] [Related]  

  • 58. [A clinico-experimental study of a new anticoagulant-Nitrofarin].
    Lukomskiĭ PE; Lakin KM; DaKaz'mina PV; Liusov VA
    Kardiologiia; 1968 Mar; 8(3):84-9. PubMed ID: 5654269
    [No Abstract]   [Full Text] [Related]  

  • 59. Contradictory functions of sulfatide in the blood coagulation system as coagulant and anticoagulant.
    Kyogashima M; Onaya J; Hara A; Taketomi T
    Acta Biochim Pol; 1998; 45(2):493-9. PubMed ID: 9821878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of novocainamide on the course of experimental myocardial infarct with arrhythmias in rabbits].
    Marshutina NV
    Farmakol Toksikol; 1980; 43(1):55-9. PubMed ID: 7379992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.